Medindia

X

IDEXX Laboratories to Release 2009 Second Quarter Financial Results

Saturday, September 19, 2009 General News J E 4
Advertisement


WESTBROOK, Maine, July 15 IDEXX Laboratories, Inc. (Nasdaq: IDXX), has scheduled the release of its 2009 second quarter financial results for Friday, July 24, at approximately 7:00 a.m. (eastern). The Company will conduct an analyst conference call beginning at 9:00 a.m. (eastern) on that day.

Individuals can access a live Webcast of the conference call through a link on the IDEXX Web site, www.idexx.com. An archived edition of the call will be available after 1:00 p.m. (eastern) on that day via the same link.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 800-230-1085 or 612-234-9960 and reference confirmation code 107556. Replay of the conference call will be available as of 11:00 a.m. (eastern) on July 24, through Friday, July 31, by dialing 320-365-3844 and referencing replay code 107556.

About IDEXX Laboratories

IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,700 people and offers products to customers in over 100 countries.

Contact: Bonnie Reid, Investor Relations, 1-207-556-4548

SOURCE IDEXX Laboratories, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Centocor Ortho Biotech Statement on the FDA ODAC O...
S
National Advocacy Organization Representing Home O...